BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17881136)

  • 1. Depressive disorders in Parkinson's disease may be due to a shared immune-mediated neurodegenerative process.
    Kummer A; Teixeira AL
    Med Hypotheses; 2008; 70(1):201-2. PubMed ID: 17881136
    [No Abstract]   [Full Text] [Related]  

  • 2. Dental treatment of patients with neurodegenerative disease.
    Kieser J; Jones G; Borlase G; MacFadyen E
    N Z Dent J; 1999 Dec; 95(422):130-4. PubMed ID: 10687380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of depression and anxiety in Parkinson's disease.
    Mercury MG; Tschan W; Kehoe R; Kuechler A
    Dis Mon; 2007 May; 53(5):296-301. PubMed ID: 17656191
    [No Abstract]   [Full Text] [Related]  

  • 4. Driving with Parkinson's disease: more than meets the eye.
    Newman NJ
    Ann Neurol; 2006 Oct; 60(4):387-8. PubMed ID: 17068795
    [No Abstract]   [Full Text] [Related]  

  • 5. The interplay between behavior and neurodegeneration in rat models of Parkinson's disease and stroke.
    Woodlee MT; Schallert T
    Restor Neurol Neurosci; 2004; 22(3-5):153-61. PubMed ID: 15502262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pathophysiological model of freezing of gait in Parkinson's disease.
    Lewis SJ; Barker RA
    Parkinsonism Relat Disord; 2009 Jun; 15(5):333-8. PubMed ID: 18930430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of innate immune receptors in neurodegenerative diseases: a similar pattern.
    Letiembre M; Liu Y; Walter S; Hao W; Pfander T; Wrede A; Schulz-Schaeffer W; Fassbender K
    Neurobiol Aging; 2009 May; 30(5):759-68. PubMed ID: 17905482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial factors in Parkinson's disease.
    Reese SL
    Dis Mon; 2007 May; 53(5):291-5. PubMed ID: 17656190
    [No Abstract]   [Full Text] [Related]  

  • 9. Depression in Parkinson's disease - a review.
    Wermuth L; Bech P
    Acta Neurol Scand; 2006 Nov; 114(5):360. PubMed ID: 17022788
    [No Abstract]   [Full Text] [Related]  

  • 10. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
    Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
    Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of neurodegeneration in idiopathic Parkinson's disease.
    Schulz JB
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S306-8. PubMed ID: 18267255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sense of smell, physiological ageing and neurodegenerative diseases: II. Ageing and neurodegenerative diseases].
    Fusari A; Molina JA
    Rev Neurol; 2009 Oct 1-15; 49(7):363-9. PubMed ID: 19774531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines as potential biomarkers for Parkinson's disease: a multiplex approach.
    Litteljohn D; Hayley S
    Methods Mol Biol; 2012; 934():121-44. PubMed ID: 22933144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The olfactory vector hypothesis of neurodegenerative disease: is it viable?
    Doty RL
    Ann Neurol; 2008 Jan; 63(1):7-15. PubMed ID: 18232016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Parkinson disease and depression.
    Karceski S
    Neurology; 2007 Jul; 69(4):E2-3. PubMed ID: 17646622
    [No Abstract]   [Full Text] [Related]  

  • 17. [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].
    Storch A; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):715-24. PubMed ID: 19012223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
    Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
    Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections).
    Ringheim GE; Conant K
    J Neuroimmunol; 2004 Feb; 147(1-2):43-9. PubMed ID: 14741426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.